Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Complex of C60 Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy.

Prylutska SV, Skivka LM, Didenko GV, Prylutskyy YI, Evstigneev MP, Potebnya GP, Panchuk RR, Stoika RS, Ritter U, Scharff P.

Nanoscale Res Lett. 2015 Dec;10(1):499. doi: 10.1186/s11671-015-1206-7. Epub 2015 Dec 29.

2.

Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate.

Hess JA, Khasawneh MK.

BBA Clin. 2015 Feb 7;3:152-61. doi: 10.1016/j.bbacli.2015.01.006. eCollection 2015 Jun. Review.

3.

Protecting the normal in order to better kill the cancer.

Liu B, Ezeogu L, Zellmer L, Yu B, Xu N, Joshua Liao D.

Cancer Med. 2015 Sep;4(9):1394-403. doi: 10.1002/cam4.488. Epub 2015 Jul 14. Review.

4.
5.

Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia.

Hoggatt J, Tate TA, Pelus LM.

Int J Nanomedicine. 2015 Apr 1;10:2647-52. doi: 10.2147/IJN.S55796. eCollection 2015. Review. Erratum in: Int J Nanomedicine. 2015;10:5421.

6.

Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.

Weir GM, Liwski RS, Mansour M.

Cancers (Basel). 2011 Aug 5;3(3):3114-42. doi: 10.3390/cancers3033114.

7.

Toward a universal treatment for cancer: cell inflation assisted chemotherapy.

Corcos D.

Cancer Med. 2013 Aug;2(4):421-6. doi: 10.1002/cam4.91. Epub 2013 May 28. Review.

8.

Inhibition of Ehrlich ascites carcinoma by Manilkara zapota L. stem bark in Swiss albino mice.

Osman MA, Rashid MM, Aziz MA, Habib MR, Karim MR.

Asian Pac J Trop Biomed. 2011 Dec;1(6):448-51. doi: 10.1016/S2221-1691(11)60098-1.

9.
10.

Chemotherapy agents: a primer for the interventional radiologist.

Mihlon F 4th, Ray CE Jr, Messersmith W.

Semin Intervent Radiol. 2010 Dec;27(4):384-90. doi: 10.1055/s-0030-1267852.

11.

Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948.

Spain PD, Kadan-Lottick N.

J R Soc Med. 2012 Apr;105(4):177-81. doi: 10.1258/jrsm.2012.12k013. Review. No abstract available.

12.

Bacterial Magnetosome: A Novel Biogenetic Magnetic Targeted Drug Carrier with Potential Multifunctions.

Sun J, Li Y, Liang XJ, Wang PC.

J Nanomater. 2011;2011(2011):469031-469043.

13.

Stem cells: An overview with respect to cardiovascular and renal disease.

Kumar R, Sharma A, Pattnaik AK, Varadwaj PK.

J Nat Sci Biol Med. 2010 Jul;1(1):43-52. doi: 10.4103/0976-9668.71674.

14.
15.

Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease.

Liu J, Zhao J, Hu L, Cao Y, Huang B.

Cell Mol Immunol. 2011 Jul;8(4):289-95. doi: 10.1038/cmi.2011.6. Epub 2011 Mar 21. Review.

16.

Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells.

Yu Y, Wang Y, Ren X, Tsuyada A, Li A, Liu LJ, Wang SE.

Mol Cancer Res. 2010 Dec;8(12):1633-42. doi: 10.1158/1541-7786.MCR-10-0362. Epub 2010 Oct 14.

17.

Biology-driven cancer drug development: back to the future.

Lord CJ, Ashworth A.

BMC Biol. 2010 Apr 12;8:38. doi: 10.1186/1741-7007-8-38. Review.

Items per page

Supplemental Content

Write to the Help Desk